{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:56Z","timestamp":1790745236038,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12185-018-2447-x","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T02:46:22Z","timestamp":1522723582000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-4124","authenticated-orcid":false,"given":"Ahmad","family":"Baraka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"issue":"2","key":"2447_CR1","first-page":"116","volume":"7","author":"KC Lakshmaiah","year":"2015","unstructured":"Lakshmaiah KC, Malabagi AS, Govindbabu S, Shetty R, Shetty M, Jayashree RS. Febrile neutropenia in hematological malignancies: clinical and microbiological profile and outcome in high risk patients. J Lab Phys. 2015;7(2):116\u201320.","journal-title":"J Lab Phys."},{"issue":"suppl 5","key":"2447_CR2","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27(suppl 5):v111\u20138.","journal-title":"Ann Oncol"},{"key":"2447_CR3","doi-asserted-by":"publisher","first-page":"986938","DOI":"10.1155\/2014\/986938","volume":"2014","author":"P Villafuerte-Gutierrez","year":"2014","unstructured":"Villafuerte-Gutierrez P, Villalon L, Losa JE, Henriquez-Camacho C. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Adv Hematol. 2014;2014:986938.","journal-title":"Adv Hematol"},{"issue":"14","key":"2447_CR4","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.7314\/APJCP.2015.16.14.5691","volume":"16","author":"HA El-Mahallawy","year":"2015","unstructured":"El-Mahallawy HA, Hassan SS, El-Wakil M, Moneer MM, Shalaby L. Increasing antimicrobial resistance monitored in surveillance analysis of blood stream infections in febrile neutropenic pediatric oncology patients. Asian Pac J Cancer Prev. 2015;16(14):5691\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"2447_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4143\/crt.2011.43.3.176","volume":"43","author":"DY Kim","year":"2011","unstructured":"Kim DY, Lee YS, Ahn S, Chun YH, Lim KS. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat. 2011;43(3):176\u201380.","journal-title":"Cancer Res Treat"},{"issue":"3","key":"2447_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0971-5916.156617","volume":"141","author":"J Qu","year":"2015","unstructured":"Qu J, Lu X, Liu Y, Wang X. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. Indian J Med Res. 2015;141(3):315\u201321.","journal-title":"Indian J Med Res"},{"issue":"6","key":"2447_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10156-011-0254-x","volume":"17","author":"T Shozushima","year":"2011","unstructured":"Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764\u20139.","journal-title":"J Infect Chemother"},{"issue":"8","key":"2447_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jiac.2015.04.011","volume":"21","author":"Y Arai","year":"2015","unstructured":"Arai Y, Mizugishi K, Nonomura K, Naitoh K, Takaori-Kondo A, Yamashita K. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015;21(8):564\u20139.","journal-title":"J Infect Chemother"},{"issue":"12","key":"2447_CR9","doi-asserted-by":"publisher","first-page":"e0146020","DOI":"10.1371\/journal.pone.0146020","volume":"10","author":"L Pugni","year":"2015","unstructured":"Pugni L, Pietrasanta C, Milani S, Vener C, Ronchi A, Falbo M, et al. Presepsin (soluble CD14 subtype): reference ranges of a new sepsis marker in term and preterm neonates. PLoS ONE. 2015;10(12):e0146020.","journal-title":"PLoS ONE"},{"issue":"1","key":"2447_CR10","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1038\/bcj.2015.110","volume":"6","author":"K Bochennek","year":"2016","unstructured":"Bochennek K, Hassler A, Perner C, Gilfert J, Sch\u00f6ning S, Klingebiel T, et al. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004. Blood Cancer J. 2016;6(1):e382.","journal-title":"Blood Cancer J"},{"key":"2447_CR11","doi-asserted-by":"crossref","unstructured":"Badiee P, Zareifar S, Haddadi P, Jafarian H. Incidence of fungal infections in pediatric patients with hematologic neoplasms. Arch Pediatr Infect Dis. 2017; e41317 (in press).","DOI":"10.5812\/pedinfect.41317"},{"issue":"6","key":"2447_CR12","first-page":"715","volume":"24","author":"E Olad","year":"2014","unstructured":"Olad E, Sedighi I, Mehrvar A, Tashvighi M, Fallahazad V, Hedayatiasl A, et al. Presepsin (Scd14) as a marker of serious bacterial infections in chemotherapy induced severe neutropenia. Iran J Pediatr. 2014;24(6):715\u201322.","journal-title":"Iran J Pediatr"},{"issue":"11","key":"2447_CR13","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/cncr.20275","volume":"100","author":"A Jimeno","year":"2004","unstructured":"Jimeno A, Garc\u00eda-Velasco A, del Val O, Gonz\u00e1lez-Billalabeitia E, Hernando S, Hern\u00e1ndez R, et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer. 2004;100(11):2462\u20139.","journal-title":"Cancer"},{"issue":"1","key":"2447_CR14","doi-asserted-by":"publisher","first-page":"61-viii","DOI":"10.1016\/j.cden.2007.10.002","volume":"52","author":"RV Lalla","year":"2008","unstructured":"Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients with cancer. Dent Clin N Am. 2008;52(1):61-viii.","journal-title":"Dent Clin N Am."},{"issue":"4","key":"2447_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciq147","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427\u201331.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2447_CR16","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/cc13183","volume":"18","author":"S Masson","year":"2014","unstructured":"Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, et al. Prespsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care. 2014;18(1):R6.","journal-title":"Crit Care"},{"key":"2447_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12879-016-2116-8","volume":"17","author":"Y Koizumi","year":"2017","unstructured":"Koizumi Y, Shimizu K, Shigeta M, Okuno T, Minamiguchi H, Kito K, et al. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients. BMC Infect Dis. 2017;17:27.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"2447_CR18","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1086\/427329","volume":"40","author":"C Viscoli","year":"2005","unstructured":"Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005;40(Suppl 4):S240\u20135.","journal-title":"Clin Infect Dis"},{"key":"2447_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1086\/522533","volume":"45","author":"E Castagnola","year":"2007","unstructured":"Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45:1296\u2013304.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2447_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00520-013-1978-1","volume":"22","author":"L Kitanovski","year":"2014","unstructured":"Kitanovski L, Jazbec J, Hojker S, Dergancet M. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia\/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein. Support Care Cancer. 2014;22(1):269\u201377.","journal-title":"Support Care Cancer"},{"issue":"11","key":"2447_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/BF01967785","volume":"11","author":"E Rintala","year":"1992","unstructured":"Rintala E, Irjala K, Nikoskelainen J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 1992;11(11):973\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2447_CR22","doi-asserted-by":"publisher","first-page":"e22147","DOI":"10.1002\/jcla.22147","volume":"2017","author":"Y Ebihara","year":"2017","unstructured":"Ebihara Y, Kobayashi K, Ishida A, Maeda T, Takahashi N, Taji Y, et al. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies. J Clin Lab Anal. 2017;2017:e22147.","journal-title":"J Clin Lab Anal."},{"issue":"6","key":"2447_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","volume":"18","author":"S Endo","year":"2012","unstructured":"Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891\u20137.","journal-title":"J Infect Chemother"},{"issue":"4","key":"2447_CR24","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/cc12847","volume":"17","author":"M Ulla","year":"2013","unstructured":"Ulla M, Pizzolato E, Lucchiari M, Loiacono M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013;17(4):R168.","journal-title":"Crit Care"},{"key":"2447_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9805609","author":"S Korpelainen","year":"2017","unstructured":"Korpelainen S, Intke C, H\u00e4m\u00e4l\u00e4inen S, Jantunen E, Juutilainen A, Pulkki K. Soluble CD14 as a diagnostic and prognostic biomarker in hematological patients with febrile neutropenia. Dis Mark. 2017. https:\/\/doi.org\/10.1155\/2017\/9805609 (article ID 9805609, 8 pages).","journal-title":"Dis Mark"},{"issue":"7","key":"2447_CR26","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","volume":"34","author":"B Uzzan","year":"2006","unstructured":"Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34(7):1996\u20132003.","journal-title":"Crit Care Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T19:06:14Z","timestamp":1570993574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2447-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors indicated no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}